Picture of Kobayashi Pharmaceutical logo

4967 — Kobayashi Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
Consumer DefensivesConservativeLarge CapHigh Flyer

Table: Kobayashi Pharmaceutical - 9-MTH group results

Oct 29 (Reuters)- 
             Kobayashi Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Sep 30, 2018        Sep 30, 2017     Dec 31, 2018 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              115.77              107.65           163.00    
                   (+7.5 pct)                           (+4.0 pct)  
  Operating           19.56               17.15            23.70    
                   (+14.1 pct)                          (+3.4 pct)  
  Recurring           20.59               16.99            24.80    
                   (+21.2 pct)                          (+2.5 pct)  
  Net                 14.01               11.74            17.00    
                   (+19.3 pct)                          (+7.2 pct)  
  EPS              177.29 yen          149.08 yen       215.33 yen  
  EPS Diluted      177.19 yen          148.86 yen                   
  Ann Div                               58.00 yen        61.00 yen  
  -Q2 div           31.00 yen           28.00 yen                   
  -Q4 div                               30.00 yen        30.00 yen  
  
  NOTE - Kobayashi Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4967.T

Recent news on Kobayashi Pharmaceutical

See all news